GSK, Bayer stand by CureVac following 'disappointing' COVID-19 vaccine trial flop

CureVac’s late-stage COVID-19 vaccine trial flop clearly showed that not all pandemic shots are alike. But where does that leave the German biotech and its Big Pharma partners?

For one, ongoing collaborations with Bayer and GlaxoSmithKline aren’t going anywhere for now, the companies said following the interim results drop late Wednesday.